炎性腹主动脉瘤的管理——范围综述
本范围综述检索多个数据库,纳入57篇低证据级别文献共1554例炎性腹主动脉瘤患者。患者多为男性和重度吸烟者,CTA上的袖套征具有病理特异性;开放手术修复与腔内修复相比,后者30天死亡率更低但炎症进展和晚期纤维化相关不良事件更多;糖皮质激素可用于初始基础治疗。
要点
- 炎性腹主动脉瘤占主动脉瘤的5%–10%,以腹膜后纤维化为特征,诊断常延迟。
- 慢性腹痛或背痛、体重下降、炎症标志物升高三联征高度提示诊断但很少同时出现。
- CTA袖套征见于73%–100%患者,具有病理特异性。
核心结论
- 炎性腹主动脉瘤以非特异性症状为特征,CTA上的袖套征具有病理特异性。
- 作者认为糖皮质激素可作为所有患者初始接受的基础治疗考虑。
- 低质量数据表明,与开放手术修复相比,腔内修复与更少的术中并发症和更低的围手术期死亡率相关,但晚期纤维化相关不良事件更多。
- 需要国际多中心注册研究以获取对这一具有挑战性疾病的更多认识。
研究设计与样本
- 范围综述,检索Medline、PubMed、EMBASE和Scopus中评估炎性腹主动脉瘤诊断与治疗的相关研究,遵循PRISMA方案。
- 共纳入57篇低证据级别文献,包含1554例患者,患者大多为男性和重度吸烟者。
主要发现
- 慢性腹痛或背痛、体重下降和炎症标志物升高的三联征高度提示诊断但很少同时出现,发热仅偶见。
- CTA上袖套征见于73%–100%的患者。
- 开放手术修复报告1376例,腔内修复报告178例。
- 开放手术修复与医源性肠道损伤(n=22)、泌尿系统损伤(n=7)、静脉损伤(n=30)、胰腺损伤(n=6)和脾损伤(n=5)相关。
- 腔内修复与更低的30天死亡率相关(0%–5% vs 0%–32%),两种治疗方式的1年和2年死亡率相似(分别为0%–20%和0%–36%)。
临床怎么用
- 作者认为糖皮质激素可作为所有患者初始接受的基础治疗考虑。
- 低质量数据表明,与开放手术修复相比,腔内修复与更少的术中并发症和更低的围手术期死亡率相关,但晚期纤维化相关不良事件更多。
- 需要国际多中心注册研究以获取对这一具有挑战性疾病的更多认识。
局限性
- 纳入文献为低证据级别。
- 需要国际多中心注册研究以获取更多认识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Inflammatory abdominal aortic aneurysms (InflAAAs) account for 5 - 10% of aortic aneurysms and are characterised by retroperitoneal fibrosis. Diagnosis is often delayed, and doubts remain about the optimal management strategy. This scoping review describes the current state of knowledge on InflAAAs. METHODS: Medline, PubMed, EMBASE, and Scopus were searched for relevant studies that evaluated the diagnosis and treatment of InflAAAs. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol was followed. RESULTS: Fifty-seven papers were selected (low level of evidence), which included 1 554 patients, who were mostly male and heavy smokers. A triad of chronic abdominal or back pain, weight loss, and elevated inflammatory markers was highly suggestive of the diagnosis but rarely present, and fever was noted only randomly. A mantle sign was seen on computed tomography angiography (CTA) in 73 - 100% of patients. Open surgical repair (OSR) and endovascular aortic aneurysm repair (EVAR) was reported in 1 376 and 178 patients, respectively. OSR was associated with significant iatrogenic bowel (n = 22), urinary tract system (n = 7), venous (n = 30), pancreatic (n = 6), and splenic (n = 5) injuries, while EVAR was associated with lower 30 day mortality (0 - 5% vs. 0 - 32%). One and two year mortality rates were similar between the two treatment modalities (0 - 20% and 0 - 36%, respectively). EVAR was more often associated with post-operative progression of inflammation (17% vs. 0.4%), and a higher frequency of persistent hydronephrosis (> 50%) and limb occlusion (20%). Used in < 10% of patients, corticosteroids led to complete pain relief and a reduction in peri-aortic inflammation within 6 - 18 months. CONCLUSION: InflAAAs are characterised by non-specific symptoms, with the mantle sign on CTA being pathognomonic. Corticosteroids may be considered a basic treatment that all patients should receive initially. Low quality data indicate that EVAR (vs. OSR) is associated with fewer intra-operative complications and lower peri-operative mortality but more late fibrosis related adverse events. International multicentre registries are required to gather more insights into this challenging pathology.
引用
- Caradu C, Ammollo RP, Dari L, et al. Management of Inflammatory Aortic Aneurysms - A Scoping Review. Eur J Vasc Endovasc Surg. 2023. PMID: 36623764. doi:10.1016/j.ejvs.2023.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。